PO.BCS01.09 · 生物信息与计算

CellNeighbor:患者肿瘤与细胞系模型的转录图谱,用于指导临床前模型选择

CellNeighbor: A transcriptional atlas of patient tumors and cell line models to inform preclinical model selection

海报缩略图:CellNeighbor:患者肿瘤与细胞系模型的转录图谱,用于指导临床前模型选择
编号 1466 展板 5 时间 4/20 09:00–12:00 区域 Section 5 主讲 Caitlin Simopoulos
分会场 Integrative Computational Approaches 1
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Caitlin M. A. Simopoulos, Gabrielle Persad, Otto Morris, Carlos A. Origel Marmolejo, Laura M. Richards, Kelly M. Biette

Recursion, Salt Lake City, UT

摘要 Abstract

中文摘要
临床前科学家通常基于支持某个药物项目假设的分子谱来选择用于化合物活性检测的细胞系模型。然而,这些细胞系的广泛体外培养会影响这些模型中的遗传变化,这引发了对于这些模型是否仍能代表其来源患者肿瘤的担忧。为弥合这一转化差距,我们开发了CellNeighbor,这是一个计算框架,通过将细胞系置于真实世界患者转录组数据的格局中来指导模型选择。在既有的Celligner框架(1)基础上,我们在使用Harmony(2)整合细胞系与患者谱之前,明确地鉴定并去除了与肿瘤微环境相关的基因表达变异。随后,我们将来自DepMap(3,4)的转录组谱与来自癌症基因组图谱(TCGA)的患者肿瘤数据以及来自Tempus的去标识化患者肿瘤数据进行整合,构建了一个细胞系与肿瘤的统一转录组图谱。在此图谱中,我们采用对称最近邻方法来鉴定以每个细胞系为中心的"患者邻域",以刻画与患者肿瘤转录上最相似的细胞系。此外,我们还开发了新颖的度量指标,如邻域-组织同质性评分,以量化这些关联的置信度,用于客观和自动化的决策。我们现在能够按照细胞系与真实患者肿瘤邻域的转录相似性对细胞系进行排名,以提高模型细胞系仍能代表目标患者群体的可能性。整合的临床和分子数据层生成了一个细胞系到患者的图谱,实现了针对特定患者群体量身定制的细胞系选择。总之,CellNeighbor提供了一种稳健的方法来鉴定与患者肿瘤高度相似的细胞系模型,最终旨在提高临床前发现向临床应用转化的可能性。 1. Warren, A., Chen, Y., Jones, A. 等. Global computational alignment of tumor and cell line transcriptional profiles. Nat Commun 12, 22 (2021). https://doi.org/10.1038/s41467-020-20294-x 2. Korsunsky, I., Millard, N., Fan, J. 等. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16, 1289-1296 (2019). https://doi.org/10.1038/s41592-019-0619-0 3. DepMap, Broad (2025). DepMap Public 25Q3. Dataset. depmap.org 4. Arafeh, R., Shibue, T., Dempster, J.M. 等. The present and future of the Cancer Dependency Map. Nat Rev Cancer 25, 59-73 (2025). https://doi.org/10.1038/s41568-024-00763-x
查看英文原文 English abstract
Preclinical scientists typically select cell line models for compound activity assays based on molecular profiles that support a drug program's hypothesis. However, extensive in vitro culturing of these cell lines can influence genetic changes in these models raising concerns about whether these models still represent the patient tumors from which they were derived. To address this translational gap, we developed CellNeighbor, a computational framework that guides model selection by contextualizing cell lines within the landscape of real-world patient transcriptomic data. Building on the established Celligner framework (1), we explicitly identified and removed tumor microenvironment-related gene expression variability before integrating cell line and patient profiles with Harmony (2). Then, we integrated transcriptomic profiles from DepMap (3,4) with patient tumor data from The Cancer Genome Atlas (TCGA) and deidentified patient tumor data from Tempus, creating a unified transcriptomic map of cell lines and tumors. Within this map, we employ a symmetric nearest neighbor approach to identify "patient neighborhoods" centered around each cell line to characterize cell lines most transcriptionally similar to patient tumors. In addition, we have developed novel metrics, such as a neighborhood-tissue homogeneity score, to quantify the confidence of these associations for use in objective and automated decision making. We can now rank cell lines by their transcriptional similarity to neighborhoods of real patient tumors to increase the likelihood that model lines remain representative of the intended patient population. The integrated clinical and molecular data layers produce a cell line-to-patient map that enables cell line selection tailored to specific patient populations. In conclusion, CellNeighbor offers a robust method to identify cell line models that closely resemble patient tumors, ultimately aiming to increase the translatability of preclinical discoveries into clinical applications. 1.Warren, A., Chen, Y., Jones, A. et al. Global computational alignment of tumor and cell line transcriptional profiles. Nat Commun 12, 22 (2021). https://doi.org/10.1038/s41467-020-20294-x 2.Korsunsky, I., Millard, N., Fan, J. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16, 1289-1296 (2019). https://doi.org/10.1038/s41592-019-0619-0 3.DepMap, Broad (2025). DepMap Public 25Q3. Dataset. depmap.org 4.Arafeh, R., Shibue, T., Dempster, J.M. et al. The present and future of the Cancer Dependency Map. Nat Rev Cancer 25, 59-73 (2025). https://doi.org/10.1038/s41568-024-00763-x
利益披露 Disclosure
C. M. A. Simopoulos, Recursion Employment, Stock. Roche Canada Employment. G. Persad, Recursion Employment. O. Morris, Recursion Employment, Stock. C. A. Origel Marmolejo, Recursion Employment, Stock. L. M. Richards, Recursion Employment, Stock. K. M. Biette, Recursion Employment, Stock.

← 返回 AACR 2026 检索